Approval · Notice of Compliance 30242 · 2023
DILANTIN: Notice of Compliance 30242
Issued March 3, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30242
- Date
- March 3, 2023
- Company
- Upjohn Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the product labelling to align with the Plain Language Labeling (PLL) requirements.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DILANTIN | Not yet assigned | — |
Medicinal ingredients
- PHENYTOIN SODIUM 30 MG per CAP
- PHENYTOIN SODIUM 100 MG per CAP